A sustained state of vigilance will generate a different type of memory than a momentary startle, and these differences are linked to distinct signaling molecules in the brains of mice. Researchers at the RIKEN Center for Brain Science (CBS) have visualized these dynamics in the living mouse brain for the first time, observing fast and slow molecular pathways that support memory function. These processes take place in brain cells called astrocytes, revealing another important way in which these cells help neurons.
Norepinephrine, also called noradrenaline, is a dual hormone and neurotransmitter that prepares the body for action. Previous research has shown that norepinephrine release is important for modifying synapses, the connections between neurons that form and consolidate memories. Astrocytes are the crucial mediators of these changes, and the researchers were interested in observing, in real time, what happens in these cells when mice are learning. Their study was published in Nature Communications on January 24.
First, the team artificially stimulated brain cells with light, a method called optogenetics, to induce norepinephrine release. They focused on noradrenergic neurons originating in a part of the brain called the locus coeruleus. Norepinephrine release launched two distinct chains of molecular events, the first involving calcium activity and the second cAMP, an important signaling molecule. Calcium levels in astrocytes were quick to become elevated following norepinephrine release, while cAMP levels had a slower but more sustained increase. "We think these fast and slow dynamics are significant because calcium elevation in astrocytes promotes synaptic plasticity, or the ability of cells to form new memory connections, while cAMP elevation mobilizes energy metabolism for memory consolidation," said Hajime Hirase, senior author and team leader at RIKEN CBS.
To see how these fast and slow molecular responses are triggered naturally, mice were given random air puffs to the face to evoke a brief startle response. In this situation, cAMP levels did not go up at all, while calcium became elevated as previously observed. In a second experiment, mice were given a foot shock coupled with a sound to create a fear memory. When they heard the sound again, the mice would freeze in anticipation of a shock. This time, cAMP levels were noticeably elevated, while calcium levels also rose but quickly tapered off. "When mice are in this sustained state of vigilance, a lot of norepinephrine is released, coupled with gradually building cAMP," explains first author Yuki Oe, a research scientist in Hirase's group. "This reflects how the astrocytes support the formation of fear memory." Neither calcium nor cAMP responses were seen in mice that were given norepinephrine-blocking drugs, indicating that norepinephrine release is indeed the trigger for these changes.
The short-term and long-term consequences of norepinephrine release in the brain thus depend on the situation and behavior. Memory formation, in particular, seems to be supported by increases in cAMP levels, while transient or low vigilance states involve short-term elevated calcium. "One of the effects of cAMP is to break down glycogen for quick energy in a fight-or-flight situation," comments Hirase. "This boosting of energy metabolism could help consolidate memories over longer time scales, while rapid calcium boosts could lower the threshold for synaptic plasticity." Explore further More information: Oe et al. (2020) Distinct temporal integration of noradrenaline signaling by astrocytic second messengers during vigilance. Nature Communications (2020). DOI: 10.1038/s41467-020-14378-x Journal information: Provided by RIKEN Citation : Brain-cell helpers powered by norepinephrine during fear-memory formation (2020, January 24) retrieved 24 January 2020 from https://medicalxpress.com/news/2020-01-brain-cell-helpers-powered-norepinephrine-fear-memory.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
Also in Industry News
How to decide whether or not to start treatment for prostate cancer?
Analysis of the SARS-CoV-2 proteome via visual tools
$65m investment increases British Patient Capital’s exposure to life sciences and health technology